Using a Case Study Approach to Describing the Key Drivers of Reimbursement Strategy Planning-Susan Rowinski-06/17/2014 - 8:30am

Event Information
Event Topic: 
Using a Case Study Approach to Describing the Key Drivers of Reimbursement Strategy Planning
Event Date: 
06/17/2014 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Susan Rowinski
Event Speaker Title: 
President
Event Speaker Company: 
Rowinski Group LLC
Event Speaker Bio: 


Susan Rowinski

Ms. Rowinski is the President of Rowinski Group LLC, a reimbursement and marketing economics consultancy with its main office in the Silicon Valley- San Francisco bay area. Private and public investors and companies in the medical device markets retain the Rowinski Group LLC.

Ms. Rowinski has a combined 23 years of operating management and consulting experience in the medical device and imaging markets. Her industry experience includes senior management responsibility for reimbursement, marketing and sales at Medtronic, PharmaSonics, Cardiometrics and ATL.

Susan is familiar with all stages of company and product development and advancing companies through the product development, launch and commercial phases. She has raised venture capital and has managed strategic corporate partners. Ms. Rowinski has secured payer approvals and has been responsible for three market introductions that included the U.S., Euro-zone and Japan markets and has managed sales territories.

Susan is an advisor on reimbursement matters to the National Institutes of Health (NIH) and National Science Foundation (NSF). She is a member of the Purdue University Weldon Biomedical Advisory Board.

Ms. Rowinski holds a M. S. in Engineering/Bioengineering from the University of Washington (Seattle, WA) and a B.S. in Health Physics from Purdue University (West Lafayette, IN).

Event Details
Cost: 
$0
Event Details: 

This presentation is relevant to those who are developing or selling medical mobile app/ telemedicine devices, molecular Invitro DX tests, conventional medical devices or imaging systems. From a health insurers’ perspective, these seemingly disparate medical technologies have one thing in common, their reimbursement approval processes are very similar, which is the reason this presentation is relevant.

Susan's presentation has three objectives. First, to describe the key strategic decisions that will define the scope of your reimbursement plan. She will discuss what are these decisions and why they are important to the commercial success of your medical technology.

After laying the strategic groundwork, the next step will be to apply them into a planning framework you can use after the presentation. This is the second objective of the presentation, to show how and when to begin reimbursement planning.

Her final objective is to make the case that reimbursement planning and execution should begin before FDA approval or clearance. The most successful reimbursement plans begin early in the product development cycle.

She will use real world case studies to help me demonstrate the three objectives described above and how reimbursement planning impacted company operations and fundraising efforts.